146 results match your criteria: "and Claude Bernard University[Affiliation]"
J Clin Med
November 2024
Department of Spine Surgery, Hôpital Pierre Wertheimer, Hospices Civils de Lyon, and Claude Bernard University of Lyon 1, 69367 Lyon, France.
Cardiol J
October 2024
Department of Interventional Cardiology, Cardiovascular Hospital and Claude Bernard University, INSERM Unit 1060 CARMEN, Lyon, France.
EuroIntervention
September 2024
Interventional Cardiology Department, Nantes Université, CHU Nantes, L'institut du thorax, Nantes, France.
Background: Large datasets of transcatheter aortic valve implantation (TAVI) for pure aortic valve regurgitation (PAVR) are scarce.
Aims: We aimed to report procedural safety and long-term clinical events (CE) in a contemporary cohort of PAVR patients treated with new-generation devices (NGD).
Methods: Patients with grade III/IV PAVR enrolled in the FRANCE-TAVI Registry were selected.
Talanta
October 2024
Department of Chemistry and Biochemistry, Florida International University, Miami, FL, USA. Electronic address:
J Evid Based Med
June 2024
Pharmacy Department, University of Lyon, Lyon, France.
PLoS One
May 2024
Pharmacy Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.
Objectives: Left atrial appendage occlusion during cardiac surgery is a therapeutic option for stroke prevention in patients with atrial fibrillation. The effectiveness and safety of left atrial appendage occlusion have been evaluated in several studies, including the LAAOS-III trial. While these studies have demonstrated efficacy and safety, the long-term economic impact of this surgical technique has not yet been assessed.
View Article and Find Full Text PDFBlood
July 2024
Centre de Référence des Neutropénies Chroniques, Assistance Publique-Hôpitaux de Paris Sorbonne Université-Hôpital d'Enfants Armand-Trousseau, Paris, France.
Acta Neurochir (Wien)
March 2024
Department of Spine and Spinal Cord Surgery, Pierre Wertheimer Hospital, Hospices Civils de Lyon, 59 Boulevard Pinel, 696777, Lyon-Bron, France.
J Clin Endocrinol Metab
August 2024
Endocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Context: Hypoparathyroidism is a rare disorder characterized by a deficiency in PTH resulting in hypocalcemia, hyperphosphatemia, and hypercalciuria. Eneboparatide is an investigational peptide agonist of the PTH1 receptor for the treatment of chronic hypoparathyroidism (HP).
Objective: To evaluate the efficacy, safety, and tolerability of eneboparatide in HP patients.
J Clin Anesth
June 2024
Centre Lyonnais d'Enseignement par la Simulation en Santé (CLESS), SimuLyon. Claude Bernard University Lyon 1-Hospices Civils de Lyon, Lyon, France; Neurologic Intensive care and Anesthesiology, Hospices Civils de Lyon, Pierre Wertheimer Hospital and Claude Bernard University Lyon 1 - Neuroscience Research Center, Lyon, France.
Knee Surg Sports Traumatol Arthrosc
November 2023
Department of Pediatric Orthopaedic Surgery, Lyon University Hospital for Mother and Children and Claude Bernard University Lyon I., Hospices Civils de Lyon, 59 Boulevard Pinel, 69677, Bron, France.
Purpose: Despite an improved understanding of discoid lateral meniscus (DLM), the treatment of symptomatic discoid lateral meniscus remains controversial.
Methods: The aim of this retrospective, single-centred, consecutive-case study was to evaluate the clinical outcome of 60 DLM treated arthroscopically by the "meniscoplasty or saucerisation-suture" technique in children and adolescents [median (range) age 11 (4-17) years], and to investigate surgical failures. The instability was assessed before any saucerisation.
World Neurosurg
October 2023
Department of Spine and Spinal Cord Surgery, Hôpital Pierre Wertheimer, Hospices Civils de Lyon, and Claude Bernard University of Lyon 1, Lyon, France; Laboratory of Biomechanics, École nationale supérieure d'Arts et Métiers, Arts et Metiers ParisTech, Paris, France.
Objective: This study aims to introduce a method of three-dimensional (3D) volume magnetic resonance imaging (MRI) measurements to evaluate the evolution of syringomyelia (SM) in adults with Chiari malformation type 1 (CM-1) after posterior fossa decompression (PFD), to provide reproducible and accurate measurements.
Methods: Radiologic and clinical data were obtained for 28 patients. MRI 3D syrinx volumes were evaluated by 2 observers using Philips Healthcare Tumor Tracking tool.
J Fungi (Basel)
June 2023
UR3738 Centre pour l'lnnovation en Cancérologie de Lyon, Team Inflammation and Immunity of the Respiratory Epithelium, Claude Bernard University-Lyon 1, 69495 Pierre Bénite, France.
Objective: To review the survival modelling used in cost-effectiveness studies evaluating an interventional procedure and to discuss implications for decision-makers.
Design: A case study of three economic evaluations that each used immature data from the EVEREST II High Surgical Risk (HSR) Study of transcatheter edge-to-edge repair (TEER) for patients with severe mitral regurgitation (MR) who were at high risk of surgery.
Setting: Estimation of patient survival in cost-effectiveness studies.
Cardiol J
March 2024
Department of Interventional Cardiology, Cardiovascular Hospital and Claude Bernard University and INSERM Unit 1060 CARMEN, Lyon, France.
Eur Heart J Acute Cardiovasc Care
April 2023
Hôpital Cardiovasculaire Louis Pradel, Clinical Investigation Center & Heart Failure Department, INSERM 1407 and INSERM 1060, Hospices Civils de Lyon and Claude Bernard University, 59 Boulevard Pinel, Bron, Lyon 69500, France.
EuroIntervention
April 2023
Department of Cardiology, Institut Arnault Tzanck, Saint-Laurent-du-Var, France.
PLoS One
January 2023
Warwick Medical School, University of Warwick, Coventry, United Kingdom.
When updated clinical trial data becomes available reassessing the cost-effectiveness of technologies may modify estimates and influence decision-making. We investigated the impact of updated trial outcomes on the cost-effectiveness of percutaneous mitral repair (PR) for secondary mitral regurgitation. We updated our previous three-state time-varying Markov model to assess the cost-effectiveness of PR + guideline directed medical treatment (GDMT) versus GDMT alone.
View Article and Find Full Text PDFNeurol Genet
December 2022
Neurology Department (V.B., L.M.), University Hospital; Jean Monnet University (V.B., L.M.); Genetics Department (F.R.), University Hospital, St-Etienne; Team "Central Integration of Pain" (F.M., L.M.), Lyon Neuroscience Research Center, INSERM U 1028, CNRS UMR 5292; and Claude Bernard University Lyon 1 (F.M.), University of Lyon; Functional Neurology and Epilepsy Department (F.M.), Neurological Hospital, Hospices Civils de Lyon, France.
J Spine Surg
September 2022
Department of Spine and Spinal Cord Surgery, Pierre Wertheimer Hospital, Hospices Civils de Lyon, and Claude Bernard University of Lyon 1, Lyon-Bron, France.
Background: Spinal cavernous malformations (CMs) are slow flow venous vascular malformations which can occur in vertebral body, epidural space or intramedullary. Only 7 cases were described confined in foraminal space. Cowden syndrome (CS) is an autosomal dominant genodermatosis that may present and develop vascular malformations, which include CM.
View Article and Find Full Text PDFNeurochirurgie
December 2022
Department of Spine and Spinal Cord Surgery, Hôpital Pierre Wertheimer, Hospices Civils de Lyon, and Claude Bernard University of Lyon 1, 59 boulevard Pinel, 69677 Lyon-Bron, France; Laboratory of Biomechanics, ENSAM, Arts et Metiers Paris Tech, 153, boulevard de l'Hôpital, 75013 Paris, France.
Background: Cervical flavum ligament ossification (C-OLF) is very rare source of myeloradiculopathy. Less than 100 cases have been reported in modern English literature up to 2020. Association between C-OLF and Diffuse Idiopathic Skeletal Hyperostosis (DISH) at cervical level has never been described.
View Article and Find Full Text PDFEuroIntervention
August 2022
Hôpital Cardiovasculaire Louis Pradel, Chirurgie Cardio-Vasculaire et Transplantation Cardiaque, Hospices Civils de Lyon and Claude Bernard University, Lyon, France.
Background: In the MITRA-FR trial, transcatheter mitral valve repair (TMVR) was not associated with a 2-year clinical benefit in patients with secondary mitral regurgitation (SMR).
Aims: This landmark analysis aimed at investigating a potential reduction of the hospitalisation rate for heart failure (HF) between 12 and 24 months after inclusion in the MITRA-FR trial in patients randomised to the intervention group (TMVR with the MitraClip device), as compared with patients randomised to the control group (guideline-directed medical therapy [GDMT]).
Methods: The MITRA-FR trial randomised 307 patients with SMR for TMVR on top of GDMT (TMVR group; n=152) or for GDMT alone (control group; n=155).
Nat Rev Cardiol
October 2022
Massachusetts General Hospital, Boston, MA, USA.